The Dissolving Stent That Leaves Your Artery Healthier Than Before?

Highlighted at ISET 2026 by Dr. Andrew Holden

If you have severe PAD affecting the arteries below the knee, your doctor has probably told you that this area is one of the hardest to treat. Traditional metal stents do not work well there. Balloon angioplasty alone often leads to the artery narrowing again within months. For a long time, patients and doctors were stuck in a frustrating cycle of procedures with no great long-term solution.

That is starting to change.

What Is a Bioresorbable Scaffold?

Think of it like a temporary internal cast for your artery. A bioresorbable scaffold is placed inside the blocked vessel to hold it open and deliver healing medication directly to the artery wall. Then, over the course of about three years, the scaffold is naturally absorbed into the body, like dissolving stitches, leaving only a healed artery behind.

The big question doctors have been asking since this technology arrived is: what actually happens to the artery after the scaffold disappears? Does it hold up on its own? Or does it collapse and re-clog?

What the 3-Year Data Shows

The answer, based on the latest evidence from the LIFE-BTK trial, is genuinely encouraging. At 3 years, the scaffold was found to be mostly dissolved, and researchers found little evidence it had ever been there. The artery appears to behave like a normal artery once the scaffold is gone.

It is worth understanding how we got here, because the story changed meaningfully over time.

At one year, the scaffold was still physically present, acting like a splint holding the artery open. Researchers could see it was working, but any talk of the artery "remodeling" itself was still theoretical. The vessel was being held open by the device, so there was no way to know yet what it would do on its own.

At three years, that changed. With the scaffold mostly dissolved, doctors could finally look at the artery itself and ask: what is it actually doing now?

The Part That Has Doctors Most Excited

Using duplex ultrasound imaging, researchers measured two things. First, the pulsatility of the treated segment — essentially, whether the artery was moving with each heartbeat the way a healthy artery should, rather than sitting rigid and stiff like a pipe. Second, arterial compliance, the vessel's ability to expand and contract naturally as blood flows through it.

Both measures showed meaningful improvement compared to what you would expect from a permanently stented artery. In plain terms: the artery appeared to be regaining some of its natural behavior after the scaffold dissolved, rather than simply holding its shape.

So why do doctors call this a "biological signal" rather than a proven finding? Because the LIFE-BTK trial was designed to answer a specific question: does this treatment save limbs and keep arteries open? It was not primarily designed to measure arterial remodeling. The remodeling data came from secondary observations... real, statistically significant, and genuinely exciting to researchers, but not yet the kind of definitive evidence you get when a trial is built from the ground up to prove a single thing.

Think of it this way: the trial set out to prove the scaffold works. At three years, doctors got a bonus finding suggesting it may also be quietly improving the artery wall in ways that could matter for years to come. That bonus finding still needs its own dedicated research to be confirmed. But it is the reason the conversation among vascular specialists shifted in 2026 from "this is a safe alternative" to "this might be doing something we have never been able to do before."

What This Means in Practical Terms

For patients, the results so far show real differences in day-to-day outcomes. Compared to balloon angioplasty, the dissolving scaffold resulted in 48% fewer repeat procedures over the study period. Fewer repeat procedures means fewer hospital visits, less recovery time, and a better chance of staying on your feet and living your life.

A Note of Honesty

This research is still maturing. The artery remodeling finding is a promising signal, not yet a fully proven outcome, and longer-term follow-up is ongoing. Researchers also noted that some patients were accruing events from their underlying disease as the scaffold dissolved, a reminder that PAD continues to progress and no single treatment is a permanent cure.

This treatment is also specifically designed for severe, limb-threatening PAD below the knee, and not every patient or every blockage will be a candidate.

The Bottom Line

For years the story on dissolving scaffolds was simply that they were a safer alternative to balloons. The 3-year data changes that headline. The scaffold does its job, disappears, and the artery appears to keep healing on its own. For patients facing the most serious forms of below-the-knee PAD, that is a genuinely meaningful step forward.

If you have been told your PAD is difficult to treat because of where the blockages are, this is worth asking your vascular specialist about..